Meet with Huma at the 41st Annual J.P.Morgan Healthcare Conference
Meet with Huma at the 41st Annual J.P.Morgan Healthcare Conference
Chief Executive Officer and Founder, Dan Vahdat, and Chief Financial and Strategy Officer, Ingeborg Oie, are excited to return in person to the main conference after the virtual meetings of the pandemic and are looking forward to reconnecting with existing, and meeting new, partners face-to-face to discuss how Huma’s digital technology advances proactive, predictive care for all patients and accelerates research and therapies.
Dan Vahdat
“I founded Huma in 2011 surrounding myself with an amazing team of 500+ Huma(ns) all driven by one purpose: to help people live longer and fuller lives. Our work to bring digital first care and research benefited more than 27 million people. This is not just a project but my life passion, a dream we are making real, the journey I started as a PhD student at Johns Hopkins”.
Ingeborg Oie
Ingeborg joined Huma in 2021. She brings experience of capital markets and scaling businesses from her role as CFO of CMR Surgical, a fast-growing medical technology company. During her time there, Ingeborg led the engagement with investors which included the $600m Series D financing round. She has experience from Goldman Sachs, Jefferies, Smith & Nephew and several healthcare company boards.
Making an impact
3000+ hospitals and clinics supported across Huma platforms to secure the most sustainable impact for patients1
Our platform can almost double clinical capacity and reduce readmission rates by >30%3
Huma's digital-first health platforms support a network of 27m patients1
Over 1 million devices have been shipped in support of our projects and we know what it takes to deploy at scale1
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Selected as one of 'The Most Important Healthcare Design of 2021' by Fast Company5
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4
Winner of the 2022 Prix Galien award for digital health, widely regarded as 'pharma's Nobel prize'4